nodes	percent_of_prediction	percent_of_DWPC	metapath
Palonosetron—CYP1A2—Dacarbazine—pancreatic cancer	0.1	0.159	CbGbCtD
Palonosetron—CYP1A2—Tamoxifen—pancreatic cancer	0.0799	0.127	CbGbCtD
Palonosetron—CYP1A2—Erlotinib—pancreatic cancer	0.0679	0.108	CbGbCtD
Palonosetron—CYP2D6—Tamoxifen—pancreatic cancer	0.0658	0.104	CbGbCtD
Palonosetron—CYP1A2—Fluorouracil—pancreatic cancer	0.0589	0.0934	CbGbCtD
Palonosetron—CYP2D6—Erlotinib—pancreatic cancer	0.056	0.0888	CbGbCtD
Palonosetron—HTR3A—enteric nervous system—pancreatic cancer	0.0519	0.816	CbGeAlD
Palonosetron—CYP3A4—Tamoxifen—pancreatic cancer	0.0419	0.0664	CbGbCtD
Palonosetron—CYP3A4—Erlotinib—pancreatic cancer	0.0356	0.0564	CbGbCtD
Palonosetron—CYP3A4—Irinotecan—pancreatic cancer	0.0321	0.051	CbGbCtD
Palonosetron—CYP2D6—Doxorubicin—pancreatic cancer	0.0276	0.0438	CbGbCtD
Palonosetron—CYP3A4—Docetaxel—pancreatic cancer	0.0236	0.0373	CbGbCtD
Palonosetron—CYP3A4—Sunitinib—pancreatic cancer	0.0234	0.0372	CbGbCtD
Palonosetron—CYP3A4—Doxorubicin—pancreatic cancer	0.0176	0.0278	CbGbCtD
Palonosetron—HTR3A—islet of Langerhans—pancreatic cancer	0.00496	0.078	CbGeAlD
Palonosetron—HTR3A—digestive system—pancreatic cancer	0.00298	0.0468	CbGeAlD
Palonosetron—CYP1A2—digestive system—pancreatic cancer	0.00154	0.0242	CbGeAlD
Palonosetron—CYP3A4—digestive system—pancreatic cancer	0.00111	0.0175	CbGeAlD
Palonosetron—CYP2D6—digestive system—pancreatic cancer	0.00109	0.0172	CbGeAlD
Palonosetron—Immune system disorder—Docetaxel—pancreatic cancer	0.000409	0.00134	CcSEcCtD
Palonosetron—Headache—Erlotinib—pancreatic cancer	0.000409	0.00134	CcSEcCtD
Palonosetron—Pain in extremity—Doxorubicin—pancreatic cancer	0.000408	0.00134	CcSEcCtD
Palonosetron—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000408	0.00133	CcSEcCtD
Palonosetron—Paraesthesia—Gemcitabine—pancreatic cancer	0.000407	0.00133	CcSEcCtD
Palonosetron—Chills—Docetaxel—pancreatic cancer	0.000406	0.00133	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000406	0.00133	CcSEcCtD
Palonosetron—Asthenia—Sunitinib—pancreatic cancer	0.000405	0.00133	CcSEcCtD
Palonosetron—Decreased appetite—Irinotecan—pancreatic cancer	0.000404	0.00132	CcSEcCtD
Palonosetron—Arrhythmia—Docetaxel—pancreatic cancer	0.000404	0.00132	CcSEcCtD
Palonosetron—Dyspnoea—Gemcitabine—pancreatic cancer	0.000404	0.00132	CcSEcCtD
Palonosetron—Abdominal pain upper—Epirubicin—pancreatic cancer	0.000403	0.00132	CcSEcCtD
Palonosetron—Insomnia—Fluorouracil—pancreatic cancer	0.000403	0.00132	CcSEcCtD
Palonosetron—Somnolence—Gemcitabine—pancreatic cancer	0.000403	0.00132	CcSEcCtD
Palonosetron—Hypokalaemia—Epirubicin—pancreatic cancer	0.000402	0.00131	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000402	0.00131	CcSEcCtD
Palonosetron—Fatigue—Irinotecan—pancreatic cancer	0.000401	0.00131	CcSEcCtD
Palonosetron—Paraesthesia—Fluorouracil—pancreatic cancer	0.0004	0.00131	CcSEcCtD
Palonosetron—Alopecia—Docetaxel—pancreatic cancer	0.0004	0.00131	CcSEcCtD
Palonosetron—Pruritus—Sunitinib—pancreatic cancer	0.0004	0.00131	CcSEcCtD
Palonosetron—Constipation—Irinotecan—pancreatic cancer	0.000398	0.0013	CcSEcCtD
Palonosetron—Pain—Irinotecan—pancreatic cancer	0.000398	0.0013	CcSEcCtD
Palonosetron—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	0.000397	0.0013	CcSEcCtD
Palonosetron—Dyspnoea—Fluorouracil—pancreatic cancer	0.000397	0.0013	CcSEcCtD
Palonosetron—Mental disorder—Docetaxel—pancreatic cancer	0.000397	0.0013	CcSEcCtD
Palonosetron—Somnolence—Fluorouracil—pancreatic cancer	0.000396	0.0013	CcSEcCtD
Palonosetron—Erythema—Docetaxel—pancreatic cancer	0.000394	0.00129	CcSEcCtD
Palonosetron—Malnutrition—Docetaxel—pancreatic cancer	0.000394	0.00129	CcSEcCtD
Palonosetron—Decreased appetite—Gemcitabine—pancreatic cancer	0.000394	0.00129	CcSEcCtD
Palonosetron—Dyspepsia—Fluorouracil—pancreatic cancer	0.000392	0.00128	CcSEcCtD
Palonosetron—Nausea—Tamoxifen—pancreatic cancer	0.000392	0.00128	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000391	0.00128	CcSEcCtD
Palonosetron—Fatigue—Gemcitabine—pancreatic cancer	0.000391	0.00128	CcSEcCtD
Palonosetron—Gastritis—Epirubicin—pancreatic cancer	0.000391	0.00128	CcSEcCtD
Palonosetron—Pain—Gemcitabine—pancreatic cancer	0.000388	0.00127	CcSEcCtD
Palonosetron—Constipation—Gemcitabine—pancreatic cancer	0.000388	0.00127	CcSEcCtD
Palonosetron—Nausea—Erlotinib—pancreatic cancer	0.000388	0.00127	CcSEcCtD
Palonosetron—Decreased appetite—Fluorouracil—pancreatic cancer	0.000387	0.00127	CcSEcCtD
Palonosetron—Diarrhoea—Sunitinib—pancreatic cancer	0.000386	0.00126	CcSEcCtD
Palonosetron—Dysgeusia—Docetaxel—pancreatic cancer	0.000386	0.00126	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000385	0.00126	CcSEcCtD
Palonosetron—Abdominal distension—Epirubicin—pancreatic cancer	0.000384	0.00126	CcSEcCtD
Palonosetron—Pain—Fluorouracil—pancreatic cancer	0.000381	0.00125	CcSEcCtD
Palonosetron—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00038	0.00124	CcSEcCtD
Palonosetron—Dizziness—Sunitinib—pancreatic cancer	0.000373	0.00122	CcSEcCtD
Palonosetron—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000373	0.00122	CcSEcCtD
Palonosetron—Hypokalaemia—Doxorubicin—pancreatic cancer	0.000372	0.00122	CcSEcCtD
Palonosetron—Body temperature increased—Irinotecan—pancreatic cancer	0.000368	0.0012	CcSEcCtD
Palonosetron—Abdominal pain—Irinotecan—pancreatic cancer	0.000368	0.0012	CcSEcCtD
Palonosetron—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.000368	0.0012	CcSEcCtD
Palonosetron—Anaemia—Docetaxel—pancreatic cancer	0.000364	0.00119	CcSEcCtD
Palonosetron—Gastritis—Doxorubicin—pancreatic cancer	0.000361	0.00118	CcSEcCtD
Palonosetron—Vomiting—Sunitinib—pancreatic cancer	0.000359	0.00117	CcSEcCtD
Palonosetron—Body temperature increased—Gemcitabine—pancreatic cancer	0.000358	0.00117	CcSEcCtD
Palonosetron—Rash—Sunitinib—pancreatic cancer	0.000356	0.00116	CcSEcCtD
Palonosetron—Dermatitis—Sunitinib—pancreatic cancer	0.000356	0.00116	CcSEcCtD
Palonosetron—Abdominal distension—Doxorubicin—pancreatic cancer	0.000355	0.00116	CcSEcCtD
Palonosetron—Headache—Sunitinib—pancreatic cancer	0.000354	0.00116	CcSEcCtD
Palonosetron—Body temperature increased—Fluorouracil—pancreatic cancer	0.000352	0.00115	CcSEcCtD
Palonosetron—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000344	0.00113	CcSEcCtD
Palonosetron—Hypersensitivity—Irinotecan—pancreatic cancer	0.000343	0.00112	CcSEcCtD
Palonosetron—Convulsion—Docetaxel—pancreatic cancer	0.000341	0.00112	CcSEcCtD
Palonosetron—Hypertension—Docetaxel—pancreatic cancer	0.00034	0.00111	CcSEcCtD
Palonosetron—Myalgia—Docetaxel—pancreatic cancer	0.000335	0.0011	CcSEcCtD
Palonosetron—Arthralgia—Docetaxel—pancreatic cancer	0.000335	0.0011	CcSEcCtD
Palonosetron—Nausea—Sunitinib—pancreatic cancer	0.000335	0.0011	CcSEcCtD
Palonosetron—Asthenia—Irinotecan—pancreatic cancer	0.000334	0.00109	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000333	0.00109	CcSEcCtD
Palonosetron—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000328	0.00107	CcSEcCtD
Palonosetron—Dry mouth—Docetaxel—pancreatic cancer	0.000328	0.00107	CcSEcCtD
Palonosetron—Asthenia—Gemcitabine—pancreatic cancer	0.000325	0.00106	CcSEcCtD
Palonosetron—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000322	0.00105	CcSEcCtD
Palonosetron—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000322	0.00105	CcSEcCtD
Palonosetron—Epistaxis—Epirubicin—pancreatic cancer	0.000321	0.00105	CcSEcCtD
Palonosetron—Pruritus—Gemcitabine—pancreatic cancer	0.000321	0.00105	CcSEcCtD
Palonosetron—Infection—Docetaxel—pancreatic cancer	0.00032	0.00104	CcSEcCtD
Palonosetron—Sinusitis—Epirubicin—pancreatic cancer	0.000319	0.00104	CcSEcCtD
Palonosetron—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000318	0.00104	CcSEcCtD
Palonosetron—Diarrhoea—Irinotecan—pancreatic cancer	0.000318	0.00104	CcSEcCtD
Palonosetron—Shock—Docetaxel—pancreatic cancer	0.000316	0.00103	CcSEcCtD
Palonosetron—Nervous system disorder—Docetaxel—pancreatic cancer	0.000315	0.00103	CcSEcCtD
Palonosetron—Pruritus—Fluorouracil—pancreatic cancer	0.000315	0.00103	CcSEcCtD
Palonosetron—Tachycardia—Docetaxel—pancreatic cancer	0.000314	0.00103	CcSEcCtD
Palonosetron—Skin disorder—Docetaxel—pancreatic cancer	0.000312	0.00102	CcSEcCtD
Palonosetron—Bradycardia—Epirubicin—pancreatic cancer	0.000311	0.00102	CcSEcCtD
Palonosetron—Diarrhoea—Gemcitabine—pancreatic cancer	0.00031	0.00101	CcSEcCtD
Palonosetron—Dizziness—Irinotecan—pancreatic cancer	0.000308	0.00101	CcSEcCtD
Palonosetron—Anorexia—Docetaxel—pancreatic cancer	0.000307	0.001	CcSEcCtD
Palonosetron—Diarrhoea—Fluorouracil—pancreatic cancer	0.000305	0.000997	CcSEcCtD
Palonosetron—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000302	0.000986	CcSEcCtD
Palonosetron—Hypotension—Docetaxel—pancreatic cancer	0.000301	0.000983	CcSEcCtD
Palonosetron—Connective tissue disorder—Epirubicin—pancreatic cancer	0.0003	0.000981	CcSEcCtD
Palonosetron—Urethral disorder—Epirubicin—pancreatic cancer	0.000299	0.000979	CcSEcCtD
Palonosetron—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000298	0.000973	CcSEcCtD
Palonosetron—Epistaxis—Doxorubicin—pancreatic cancer	0.000297	0.000971	CcSEcCtD
Palonosetron—Vomiting—Irinotecan—pancreatic cancer	0.000296	0.000967	CcSEcCtD
Palonosetron—Sinusitis—Doxorubicin—pancreatic cancer	0.000295	0.000966	CcSEcCtD
Palonosetron—Dizziness—Fluorouracil—pancreatic cancer	0.000295	0.000964	CcSEcCtD
Palonosetron—Rash—Irinotecan—pancreatic cancer	0.000293	0.000959	CcSEcCtD
Palonosetron—Dermatitis—Irinotecan—pancreatic cancer	0.000293	0.000958	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000293	0.000958	CcSEcCtD
Palonosetron—Headache—Irinotecan—pancreatic cancer	0.000291	0.000953	CcSEcCtD
Palonosetron—Insomnia—Docetaxel—pancreatic cancer	0.000291	0.000951	CcSEcCtD
Palonosetron—Paraesthesia—Docetaxel—pancreatic cancer	0.000289	0.000944	CcSEcCtD
Palonosetron—Vomiting—Gemcitabine—pancreatic cancer	0.000288	0.000942	CcSEcCtD
Palonosetron—Bradycardia—Doxorubicin—pancreatic cancer	0.000288	0.000941	CcSEcCtD
Palonosetron—Dyspnoea—Docetaxel—pancreatic cancer	0.000287	0.000938	CcSEcCtD
Palonosetron—Somnolence—Docetaxel—pancreatic cancer	0.000286	0.000935	CcSEcCtD
Palonosetron—Rash—Gemcitabine—pancreatic cancer	0.000286	0.000934	CcSEcCtD
Palonosetron—Dermatitis—Gemcitabine—pancreatic cancer	0.000285	0.000934	CcSEcCtD
Palonosetron—Eye disorder—Epirubicin—pancreatic cancer	0.000285	0.000933	CcSEcCtD
Palonosetron—Tinnitus—Epirubicin—pancreatic cancer	0.000285	0.000931	CcSEcCtD
Palonosetron—Headache—Gemcitabine—pancreatic cancer	0.000284	0.000928	CcSEcCtD
Palonosetron—Cardiac disorder—Epirubicin—pancreatic cancer	0.000283	0.000927	CcSEcCtD
Palonosetron—Vomiting—Fluorouracil—pancreatic cancer	0.000283	0.000926	CcSEcCtD
Palonosetron—Dyspepsia—Docetaxel—pancreatic cancer	0.000283	0.000926	CcSEcCtD
Palonosetron—Rash—Fluorouracil—pancreatic cancer	0.000281	0.000919	CcSEcCtD
Palonosetron—Dermatitis—Fluorouracil—pancreatic cancer	0.000281	0.000918	CcSEcCtD
Palonosetron—Decreased appetite—Docetaxel—pancreatic cancer	0.00028	0.000914	CcSEcCtD
Palonosetron—Headache—Fluorouracil—pancreatic cancer	0.000279	0.000913	CcSEcCtD
Palonosetron—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000279	0.000912	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000278	0.000908	CcSEcCtD
Palonosetron—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000278	0.000908	CcSEcCtD
Palonosetron—Fatigue—Docetaxel—pancreatic cancer	0.000277	0.000907	CcSEcCtD
Palonosetron—Angiopathy—Epirubicin—pancreatic cancer	0.000277	0.000906	CcSEcCtD
Palonosetron—Urethral disorder—Doxorubicin—pancreatic cancer	0.000277	0.000906	CcSEcCtD
Palonosetron—Nausea—Irinotecan—pancreatic cancer	0.000276	0.000904	CcSEcCtD
Palonosetron—Immune system disorder—Epirubicin—pancreatic cancer	0.000276	0.000902	CcSEcCtD
Palonosetron—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000275	0.0009	CcSEcCtD
Palonosetron—Pain—Docetaxel—pancreatic cancer	0.000275	0.000899	CcSEcCtD
Palonosetron—Constipation—Docetaxel—pancreatic cancer	0.000275	0.000899	CcSEcCtD
Palonosetron—Chills—Epirubicin—pancreatic cancer	0.000274	0.000896	CcSEcCtD
Palonosetron—Arrhythmia—Epirubicin—pancreatic cancer	0.000273	0.000892	CcSEcCtD
Palonosetron—Alopecia—Epirubicin—pancreatic cancer	0.00027	0.000882	CcSEcCtD
Palonosetron—Nausea—Gemcitabine—pancreatic cancer	0.000269	0.00088	CcSEcCtD
Palonosetron—Mental disorder—Epirubicin—pancreatic cancer	0.000268	0.000875	CcSEcCtD
Palonosetron—Malnutrition—Epirubicin—pancreatic cancer	0.000266	0.000869	CcSEcCtD
Palonosetron—Erythema—Epirubicin—pancreatic cancer	0.000266	0.000869	CcSEcCtD
Palonosetron—Nausea—Fluorouracil—pancreatic cancer	0.000265	0.000866	CcSEcCtD
Palonosetron—Eye disorder—Doxorubicin—pancreatic cancer	0.000264	0.000863	CcSEcCtD
Palonosetron—Tinnitus—Doxorubicin—pancreatic cancer	0.000263	0.000861	CcSEcCtD
Palonosetron—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000263	0.00086	CcSEcCtD
Palonosetron—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000262	0.000857	CcSEcCtD
Palonosetron—Flatulence—Epirubicin—pancreatic cancer	0.000262	0.000856	CcSEcCtD
Palonosetron—Dysgeusia—Epirubicin—pancreatic cancer	0.00026	0.000851	CcSEcCtD
Palonosetron—Angiopathy—Doxorubicin—pancreatic cancer	0.000256	0.000838	CcSEcCtD
Palonosetron—Immune system disorder—Doxorubicin—pancreatic cancer	0.000255	0.000834	CcSEcCtD
Palonosetron—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000255	0.000833	CcSEcCtD
Palonosetron—Body temperature increased—Docetaxel—pancreatic cancer	0.000254	0.000831	CcSEcCtD
Palonosetron—Abdominal pain—Docetaxel—pancreatic cancer	0.000254	0.000831	CcSEcCtD
Palonosetron—Chills—Doxorubicin—pancreatic cancer	0.000253	0.000829	CcSEcCtD
Palonosetron—Arrhythmia—Doxorubicin—pancreatic cancer	0.000252	0.000825	CcSEcCtD
Palonosetron—Alopecia—Doxorubicin—pancreatic cancer	0.00025	0.000816	CcSEcCtD
Palonosetron—Mental disorder—Doxorubicin—pancreatic cancer	0.000248	0.000809	CcSEcCtD
Palonosetron—Erythema—Doxorubicin—pancreatic cancer	0.000246	0.000804	CcSEcCtD
Palonosetron—Malnutrition—Doxorubicin—pancreatic cancer	0.000246	0.000804	CcSEcCtD
Palonosetron—Anaemia—Epirubicin—pancreatic cancer	0.000246	0.000803	CcSEcCtD
Palonosetron—Flatulence—Doxorubicin—pancreatic cancer	0.000242	0.000792	CcSEcCtD
Palonosetron—Dysgeusia—Doxorubicin—pancreatic cancer	0.000241	0.000788	CcSEcCtD
Palonosetron—Hypersensitivity—Docetaxel—pancreatic cancer	0.000237	0.000775	CcSEcCtD
Palonosetron—Asthenia—Docetaxel—pancreatic cancer	0.000231	0.000755	CcSEcCtD
Palonosetron—Convulsion—Epirubicin—pancreatic cancer	0.00023	0.000753	CcSEcCtD
Palonosetron—Hypertension—Epirubicin—pancreatic cancer	0.000229	0.00075	CcSEcCtD
Palonosetron—Pruritus—Docetaxel—pancreatic cancer	0.000228	0.000744	CcSEcCtD
Palonosetron—Anaemia—Doxorubicin—pancreatic cancer	0.000227	0.000743	CcSEcCtD
Palonosetron—Arthralgia—Epirubicin—pancreatic cancer	0.000226	0.00074	CcSEcCtD
Palonosetron—Myalgia—Epirubicin—pancreatic cancer	0.000226	0.00074	CcSEcCtD
Palonosetron—Anxiety—Epirubicin—pancreatic cancer	0.000226	0.000737	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000225	0.000735	CcSEcCtD
Palonosetron—Discomfort—Epirubicin—pancreatic cancer	0.000224	0.000731	CcSEcCtD
Palonosetron—Dry mouth—Epirubicin—pancreatic cancer	0.000221	0.000724	CcSEcCtD
Palonosetron—Diarrhoea—Docetaxel—pancreatic cancer	0.00022	0.00072	CcSEcCtD
Palonosetron—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000217	0.000709	CcSEcCtD
Palonosetron—Infection—Epirubicin—pancreatic cancer	0.000216	0.000705	CcSEcCtD
Palonosetron—Shock—Epirubicin—pancreatic cancer	0.000213	0.000698	CcSEcCtD
Palonosetron—Convulsion—Doxorubicin—pancreatic cancer	0.000213	0.000697	CcSEcCtD
Palonosetron—Nervous system disorder—Epirubicin—pancreatic cancer	0.000213	0.000696	CcSEcCtD
Palonosetron—Dizziness—Docetaxel—pancreatic cancer	0.000213	0.000695	CcSEcCtD
Palonosetron—Hypertension—Doxorubicin—pancreatic cancer	0.000212	0.000694	CcSEcCtD
Palonosetron—Tachycardia—Epirubicin—pancreatic cancer	0.000212	0.000692	CcSEcCtD
Palonosetron—Skin disorder—Epirubicin—pancreatic cancer	0.000211	0.000689	CcSEcCtD
Palonosetron—Myalgia—Doxorubicin—pancreatic cancer	0.000209	0.000685	CcSEcCtD
Palonosetron—Arthralgia—Doxorubicin—pancreatic cancer	0.000209	0.000685	CcSEcCtD
Palonosetron—Anxiety—Doxorubicin—pancreatic cancer	0.000209	0.000682	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000208	0.00068	CcSEcCtD
Palonosetron—Discomfort—Doxorubicin—pancreatic cancer	0.000207	0.000676	CcSEcCtD
Palonosetron—Anorexia—Epirubicin—pancreatic cancer	0.000207	0.000676	CcSEcCtD
Palonosetron—Dry mouth—Doxorubicin—pancreatic cancer	0.000205	0.00067	CcSEcCtD
Palonosetron—Vomiting—Docetaxel—pancreatic cancer	0.000204	0.000669	CcSEcCtD
Palonosetron—Rash—Docetaxel—pancreatic cancer	0.000203	0.000663	CcSEcCtD
Palonosetron—Hypotension—Epirubicin—pancreatic cancer	0.000203	0.000663	CcSEcCtD
Palonosetron—Dermatitis—Docetaxel—pancreatic cancer	0.000203	0.000663	CcSEcCtD
Palonosetron—Headache—Docetaxel—pancreatic cancer	0.000201	0.000659	CcSEcCtD
Palonosetron—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000201	0.000656	CcSEcCtD
Palonosetron—Infection—Doxorubicin—pancreatic cancer	0.000199	0.000652	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000198	0.000646	CcSEcCtD
Palonosetron—Shock—Doxorubicin—pancreatic cancer	0.000197	0.000646	CcSEcCtD
Palonosetron—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000197	0.000644	CcSEcCtD
Palonosetron—Insomnia—Epirubicin—pancreatic cancer	0.000196	0.000642	CcSEcCtD
Palonosetron—Tachycardia—Doxorubicin—pancreatic cancer	0.000196	0.000641	CcSEcCtD
Palonosetron—Skin disorder—Doxorubicin—pancreatic cancer	0.000195	0.000638	CcSEcCtD
Palonosetron—Paraesthesia—Epirubicin—pancreatic cancer	0.000195	0.000637	CcSEcCtD
Palonosetron—Dyspnoea—Epirubicin—pancreatic cancer	0.000193	0.000632	CcSEcCtD
Palonosetron—Somnolence—Epirubicin—pancreatic cancer	0.000193	0.000631	CcSEcCtD
Palonosetron—Anorexia—Doxorubicin—pancreatic cancer	0.000191	0.000626	CcSEcCtD
Palonosetron—Nausea—Docetaxel—pancreatic cancer	0.000191	0.000625	CcSEcCtD
Palonosetron—Dyspepsia—Epirubicin—pancreatic cancer	0.000191	0.000624	CcSEcCtD
Palonosetron—Decreased appetite—Epirubicin—pancreatic cancer	0.000189	0.000617	CcSEcCtD
Palonosetron—Hypotension—Doxorubicin—pancreatic cancer	0.000188	0.000613	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000187	0.000612	CcSEcCtD
Palonosetron—Fatigue—Epirubicin—pancreatic cancer	0.000187	0.000612	CcSEcCtD
Palonosetron—Pain—Epirubicin—pancreatic cancer	0.000186	0.000607	CcSEcCtD
Palonosetron—Constipation—Epirubicin—pancreatic cancer	0.000186	0.000607	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000183	0.000598	CcSEcCtD
Palonosetron—Insomnia—Doxorubicin—pancreatic cancer	0.000182	0.000594	CcSEcCtD
Palonosetron—Paraesthesia—Doxorubicin—pancreatic cancer	0.00018	0.000589	CcSEcCtD
Palonosetron—Dyspnoea—Doxorubicin—pancreatic cancer	0.000179	0.000585	CcSEcCtD
Palonosetron—Somnolence—Doxorubicin—pancreatic cancer	0.000178	0.000584	CcSEcCtD
Palonosetron—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000177	0.00058	CcSEcCtD
Palonosetron—Dyspepsia—Doxorubicin—pancreatic cancer	0.000177	0.000578	CcSEcCtD
Palonosetron—Decreased appetite—Doxorubicin—pancreatic cancer	0.000174	0.000571	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000173	0.000567	CcSEcCtD
Palonosetron—Fatigue—Doxorubicin—pancreatic cancer	0.000173	0.000566	CcSEcCtD
Palonosetron—Pain—Doxorubicin—pancreatic cancer	0.000172	0.000561	CcSEcCtD
Palonosetron—Constipation—Doxorubicin—pancreatic cancer	0.000172	0.000561	CcSEcCtD
Palonosetron—Abdominal pain—Epirubicin—pancreatic cancer	0.000171	0.000561	CcSEcCtD
Palonosetron—Body temperature increased—Epirubicin—pancreatic cancer	0.000171	0.000561	CcSEcCtD
Palonosetron—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000164	0.000537	CcSEcCtD
Palonosetron—Hypersensitivity—Epirubicin—pancreatic cancer	0.00016	0.000523	CcSEcCtD
Palonosetron—Abdominal pain—Doxorubicin—pancreatic cancer	0.000159	0.000519	CcSEcCtD
Palonosetron—Body temperature increased—Doxorubicin—pancreatic cancer	0.000159	0.000519	CcSEcCtD
Palonosetron—Asthenia—Epirubicin—pancreatic cancer	0.000156	0.000509	CcSEcCtD
Palonosetron—Pruritus—Epirubicin—pancreatic cancer	0.000153	0.000502	CcSEcCtD
Palonosetron—Diarrhoea—Epirubicin—pancreatic cancer	0.000148	0.000485	CcSEcCtD
Palonosetron—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000148	0.000484	CcSEcCtD
Palonosetron—Asthenia—Doxorubicin—pancreatic cancer	0.000144	0.000471	CcSEcCtD
Palonosetron—Dizziness—Epirubicin—pancreatic cancer	0.000143	0.000469	CcSEcCtD
Palonosetron—Pruritus—Doxorubicin—pancreatic cancer	0.000142	0.000464	CcSEcCtD
Palonosetron—Vomiting—Epirubicin—pancreatic cancer	0.000138	0.000451	CcSEcCtD
Palonosetron—Diarrhoea—Doxorubicin—pancreatic cancer	0.000137	0.000449	CcSEcCtD
Palonosetron—Rash—Epirubicin—pancreatic cancer	0.000137	0.000447	CcSEcCtD
Palonosetron—Dermatitis—Epirubicin—pancreatic cancer	0.000137	0.000447	CcSEcCtD
Palonosetron—Headache—Epirubicin—pancreatic cancer	0.000136	0.000444	CcSEcCtD
Palonosetron—Dizziness—Doxorubicin—pancreatic cancer	0.000133	0.000434	CcSEcCtD
Palonosetron—Nausea—Epirubicin—pancreatic cancer	0.000129	0.000421	CcSEcCtD
Palonosetron—Vomiting—Doxorubicin—pancreatic cancer	0.000128	0.000417	CcSEcCtD
Palonosetron—Rash—Doxorubicin—pancreatic cancer	0.000127	0.000414	CcSEcCtD
Palonosetron—Dermatitis—Doxorubicin—pancreatic cancer	0.000126	0.000413	CcSEcCtD
Palonosetron—Headache—Doxorubicin—pancreatic cancer	0.000126	0.000411	CcSEcCtD
Palonosetron—Nausea—Doxorubicin—pancreatic cancer	0.000119	0.00039	CcSEcCtD
